Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Vertex Pharmaceuticals Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

69 comunicati stampa

Guarda tutti i comunicati
11/06/2026
Industria
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
05/06/2026
Eventi
Industria
Biotecnologia
Farmaceutica
Sanità
Salute
Infanzia
Vetrine/Shopping
Medicina - Varie
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
03/06/2026
Eventi
Web e Social Network
Associazioni/Professionisti
Salute
Finanza
Medicina - Varie
Farmaceutica
Biotecnologia
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
01/06/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
11/05/2026
Eventi
Biotecnologia
Finanza
Salute
Associazioni/Professionisti
Farmaceutica
Vertex to Participate in Upcoming May Investor Conferences
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/05/2026
Industria
Salute
Biotecnologia
Sanità
Farmaceutica
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
04/05/2026
Mercato azionario
Web e Social Network
Telefonia e Varie
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Vertex Reports First Quarter 2026 Financial Results
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Vertex to Announce First Quarter 2026 Financial Results on May 4th
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
01/04/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Sanità
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
09/03/2026
Multimedialità
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0